Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions |
umls-concept:C0030705,
umls-concept:C0205210,
umls-concept:C0205307,
umls-concept:C0370240,
umls-concept:C0439810,
umls-concept:C0680844,
umls-concept:C0681850,
umls-concept:C0681916,
umls-concept:C0750572,
umls-concept:C1419072,
umls-concept:C1550501,
umls-concept:C1706203,
umls-concept:C2349001,
umls-concept:C2697811
|
pubmed:issue |
2
|
pubmed:dateCreated |
1986-8-14
|
pubmed:abstractText |
We describe a clinical study comparing the value of measurements of intact human PTH [hPTH(1-84)] and total PTH immunoreactivity [hPTH-(1-84) plus fragments]. A two-step immunochemical method was used to separate plasma hPTH-(1-84) from all circulating PTH fragments. The first step involved extraction and concentration of plasma PTH using solid phase antiamino-terminal PTH antibodies. After elution, the PTH immunoextract was analyzed using a sensitive mid- and C-region immunoassay. Complete separation in the immunoextraction step was proven by Sephadex G-75 gel filtration. hPTH-(1-84) values in fasting patients showed a clear distinction between those with primary hyperparathyroidism and those with nonparathyroid hypercalcemia, in contrast with small overlap in total immunoreactive PTH values. The hPTH-(1-84) values increased faster and more substantially in response to long EDTA and calcium infusion tests, compared with total PTH immunoreactivity, in normal subjects. Infusion of EDTA (10 mg/kg BW) in 5 min) elicited a readily measurable response of hPTH-(1-84) between 5 and 10 min after starting the infusion. Ingestion of 1000 mg calcium caused a decrease in hPTH-(1-84) in 1 h or less. More than 50% of patients with terminal renal failure had normal hPTH-(1-84) values despite elevated total immunoreactive PTH concentrations. We conclude that the two-step hPTH-(1-84) assay is more specific and sensitive than most regional PTH assays. Measurements of hPTH-(1-84) levels may identify disorders of parathyroid function at an early stage and provide a useful tool for the study of parathyroid physiology.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
AIM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Aug
|
pubmed:issn |
0021-972X
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
63
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
447-53
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:3088025-Administration, Oral,
pubmed-meshheading:3088025-Adolescent,
pubmed-meshheading:3088025-Adult,
pubmed-meshheading:3088025-Aged,
pubmed-meshheading:3088025-Calcium,
pubmed-meshheading:3088025-Edetic Acid,
pubmed-meshheading:3088025-Humans,
pubmed-meshheading:3088025-Hyperparathyroidism,
pubmed-meshheading:3088025-Immunochemistry,
pubmed-meshheading:3088025-Infusions, Parenteral,
pubmed-meshheading:3088025-Kidney Failure, Chronic,
pubmed-meshheading:3088025-Middle Aged,
pubmed-meshheading:3088025-Parathyroid Hormone,
pubmed-meshheading:3088025-Peptide Fragments,
pubmed-meshheading:3088025-Radioimmunoassay
|
pubmed:year |
1986
|
pubmed:articleTitle |
Clinical implications of estimation of intact parathyroid hormone (PTH) versus total immunoreactive PTH in normal subjects and hyperparathyroid patients.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|